共 99 条
[1]
Ferris RL(2004)Progress in head and neck cancer immunotherapy: can tolerance and immune suppression be reversed? ORL 66 332-340
[2]
Carvalho AL(2005)Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database Int J Cancer 114 806-816
[3]
Nishimoto IN(2004)The present and future for gene and viral therapy of directly accessible prostate and squamous cell cancers of the head and neck Future Med 1 1-9
[4]
Califano JA(1994)Purification and characterization of the Fas-ligand that induces apoptosis J Exp Med 3 873-879
[5]
Kowalski LP(1994)Human Fas ligand: gene structure, chromosomal location and species specificity Int Immunol 10 1567-1574
[6]
Norris JS(1993)Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family Cell 6 1169-1178
[7]
Norris KL(1997)Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing J Exp Med 12 2045-2050
[8]
Holman DH(1995)FAS-induced apoptosis is mediated via a ceramideinitiated RAS signaling pathway Immunity 4 341-351
[9]
El-Zawahry A(1999)Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand Hum Gene Ther 10 1641-1648
[10]
Keane TE(1999)Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells Cell Death Differ 6 175-182